NCT05794295 Sleep Architecture & Cognition in Focal Epilepsy
| NCT ID | NCT05794295 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Davis |
| Condition | Focal Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-01-24 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-01-24 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Focal Epilepsy (FE) patients and healthy controls will wear an actigraph at home for one week and a home sleep study device at home for one night. Participants will then undergo two nights of testing (at least one week apart) at California Sleep Solutions (CSS) in Sacramento, CA. During the overnight stays, participants will have EEG leads placed and possibly a headband. They will undergo cognitive testing before they go to sleep and again in the morning. During one night of testing, sounds will be played in the room (acoustic stimulation). The sounds should not wake the participants.
Eligibility Criteria
Inclusion Criteria: * Age 18 - 40 years of age * Focal Epilepsy * Capacity to fully cooperate and follow directions * no other significant neurological disorders which could affect cognition Exclusion Criteria: * Current use of any medications that can significantly affect cognition * No severe sleep apnea
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05794295 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Focal Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05794295 currently recruiting?
Yes, NCT05794295 is actively recruiting participants. Contact the research team at oyegbilechidi@health.ucdavis.edu for enrollment information.
Where is the NCT05794295 trial being conducted?
This trial is being conducted at Sacramento, United States.
Who is sponsoring the NCT05794295 clinical trial?
NCT05794295 is sponsored by University of California, Davis. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.